Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Pathology|September 9, 2020
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilitiesDane Cheasley, Abhimanyu Nigam, Magnus Zethoven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2009
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomasDariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, et al.
JCO Precision Oncology|February 9, 2022
BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF InhibitionTania Moujaber, Dariush Etemadmoghadam, Catherine J Kennedy, et al.
The Journal of Clinical Investigation|March 6, 2019
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusionChristopher R McEvoy, Huiling Xu, Kortnye Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcomeZhigang C Wang, Nicolai Juul Birkbak, Aedín C Culhane, et al.
The Journal of Pathology|April 20, 2012
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomesDavid J McBride, Dariush Etemadmoghadam, Susanna L Cooke, et al.
Journal for Immunotherapy of Cancer|January 31, 2023
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primaryAtara Posner, Tharani Sivakumaran, Andrew Pattison, et al.
Molecular Oncology|February 25, 2014
Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenograftsMonique D Topp, Lynne Hartley, Michele Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2019
Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor HistotypeMasataka Takenaka, Martin Köbel, Dale W Garsed, et al.
Cancer Research|August 17, 2012
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicinPrue A Cowin, Joshy George, Sian Fereday, et al.
Pageof 4